Skip to content
oltipraz

Structure via PubChem · Public domain (PubChem)

EntityQ7088765· pop 6· linked from 6 articles

Also known as 5-(2-Pyrazinyl)-4-methyl-1,2-dithiole-3-thione, RP 35972, 4-Methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione, RP-35,972

Oltipraz is an organosulfur compound belonging to the dithiolethione class. It acts as a schistosomicide and has been shown in rodent models to inhibit the formation of cancers in the bladder, blood, colon, kidney, liver, lung, pancreas, stomach, and trachea, skin, and mammary tissue. Clinical trials of oltipraz have failed to demonstrate efficacy and have shown significant side effects, including neurotoxicity and gastrointestinal toxicity. Oltipraz has also been shown to generate superoxide radicals, which can be toxic.

In the Vinony graph

Within Vinony's link graph, oltipraz is referenced by 6 other articles, and connects out to medication, Rodentia and digital object identifier.

Vinony files it under Antineoplastic drugs, Antiparasitic agents and Chemical pages without DrugBank identifier.

Its subject is documented across 5 Wikipedia language editions.

Chemical data

Formula
C8H6N2S3
Molecular weight
226.3 g/mol
IUPAC name
4-methyl-5-pyrazin-2-yldithiole-3-thione
SMILES
CC1=C(SSC1=S)C2=NC=CN=C2
InChIKey
CKNAQFVBEHDJQV-UHFFFAOYSA-N
XLogP
1.1
Polar surface area
108 Ų
H-bond donors
0
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 3
Molecule type
Small molecule
Indications
non-alcoholic fatty liver disease, cirrhosis of liver, lung cancer

via ChEMBL · EBI

Research

526 papers

via PubMed

Wikidata facts

Mass
225.969
Show 4 more facts
chemical formula
C₈H₆N₂S₃
canonical SMILES
CC1=C(SSC1=S)C2=NC=CN=C2
World Health Organisation international non-proprietary name
oltipraz
Commons category
Oltipraz
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

1 sections
Contents
  • References

Oltipraz is an organosulfur compound belonging to the dithiolethione class. It acts as a schistosomicide and has been shown in rodent models to inhibit the formation of cancers in the bladder, blood, colon, kidney, liver, lung, pancreas, stomach, and trachea, skin, and mammary tissue. Clinical trials of oltipraz have failed to demonstrate efficacy and have shown significant side effects, including neurotoxicity and gastrointestinal toxicity. Oltipraz has also been shown to generate superoxide radicals, which can be toxic.

== References ==

Excerpted from Wikipedia’s “oltipraz” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0

Connections

Categories